Search results
Author(s):
David Playford
Added:
3 years ago
Prof David Playford (The University of Notre Dame, Perth, AU) discusses diastolic function and mortality in 436,360 individuals using findings from the National Echo Database of Australia (NEDA).
Questions:
1. What are the objectives behind NEDA?
2. What findings did you present at ESC?
3. What were the methods of the study?
4. What were the study’s results?
5. What conclusions can be made?
6…
View more
Author(s):
Kristian Wachtell
Added:
3 years ago
Left ventricular (LV) hypertrophy is a form of pre-clinical cardiac disease that may be induced by either pressure or volume myocardial overload, as well as genetic factors and a variety of other stimuli. Pressure overload, as exemplified by aortic stenosis, and volume overload, as exemplified by regurgitant aortic or mitral valve disease or chronic anaemia, initiates growth of cardiac myocytes…
View more
Author(s):
Cesare Rusconi
Added:
3 years ago
With the widespread availability of non-invasive bedside assessment of ventricular function by echocardiography in the last two decades the paradigm of heart failure (HF), presumed to be usually due to an impaired left ventricular (LV) systolic function, has been challenged by the finding that about half of patients suffering from HF syndrome exhibit a normal LV ejection fraction (LVEF), and the…
View more
Author(s):
Otto A Smiseth
,
Anders Opdahl
,
Espen Boe
,
et al
Added:
3 years ago
Abstract
Heart failure with preserved left ventricular ejection fraction (HF-PEF), sometimes named diastolic heart failure, is a common condition most frequently seen in the elderly and is associated with arterial hypertension and left ventricular (LV) hypertrophy. Symptoms are attributed to a stiff left ventricle with compensatory elevation of filling pressure and reduced ability to increase…
View more
Adelino Leite-Moreira
Job title: Full Professor of Physiology, Pathophysiology & Cardiothoracic Surgery
Author
Diana Hui Ping Foo
Author
Author(s):
Desak Ketut Sekar Cempaka Putri
,
Andrianto Andrianto
,
Makhyan Jibril Al-Farabi
,
et al
Added:
1 year ago
Stavros Stavrakis
Research Area(s) / Expertise:
Job title: Associate Professor of Medicine; Laureate Chair in Molecular Medicine; Vice Chief, Cardiovascular Section
Author
Author(s):
Bogdan A Popescu
,
Carmen C Beladan
,
Carmen Ginghina
Added:
3 years ago
Chronic heart failure (CHF) is a major cause of morbidity and mortality in the general population with a prevalence of 1–2% in developed countries, where it accounts for 1–2% of total healthcare resources. Therefore, the economic burden of HF may become unmanageable, indicating the need for cost-effective preventative strategies and treatments.1 It has been acknowledged that about 50% of patients…
View more
Author(s):
Harald Sourij
Added:
1 year ago
ESC Congress 22 — In this short interview filmed on-site at the 2022 ESC Congress, we are joined by Prof Harald Sourij to discuss the findings of the EMMY trial (NCT03087773) on the impact of empagliflozin on cardiac function and biomarkers of heart failure in patients with acute myocardial infarction.
476 participants with acute MI were included in the trial, and were randomised to receive…
View more